The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

AKM Claessens; Reinier Timman; Jan van Busschbach; JM Bouma; JM Rademaker-Lakhai; FLG Erdkamp; VC Tjan-Heijnen; Monique Bos

doi:10.1007/s10549-019-05495-3

The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

AKM Claessens, Reinier Timman, Jan van Busschbach, JM Bouma, JM Rademaker-Lakhai, FLG Erdkamp, VC Tjan-Heijnen, Monique Bos

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

8 Downloads (Pure)

Original language	English
Pages (from-to)	677-685
Number of pages	9
Journal	Breast Cancer Research and Treatment
Volume	179
DOIs	https://doi.org/10.1007/s10549-019-05495-3
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10549-019-05495-3

REPUB_122404-OA.pdfFinal published version, 1.05 MB

Cite this

Claessens, AKM., Timman, R., van Busschbach, J., Bouma, JM., Rademaker-Lakhai, JM., Erdkamp, FLG., Tjan-Heijnen, VC., & Bos, M. (2020). The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer. Breast Cancer Research and Treatment, 179, 677-685. https://doi.org/10.1007/s10549-019-05495-3

@article{a6d9a7c7a03c43c09b0dd9eb2155b16a,

title = "The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer",

author = "AKM Claessens and Reinier Timman and {van Busschbach}, Jan and JM Bouma and JM Rademaker-Lakhai and FLG Erdkamp and VC Tjan-Heijnen and Monique Bos",

year = "2020",

doi = "10.1007/s10549-019-05495-3",

language = "English",

volume = "179",

pages = "677--685",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

}

Claessens, AKM, Timman, R, van Busschbach, J, Bouma, JM, Rademaker-Lakhai, JM, Erdkamp, FLG, Tjan-Heijnen, VC & Bos, M 2020, 'The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer', Breast Cancer Research and Treatment, vol. 179, pp. 677-685. https://doi.org/10.1007/s10549-019-05495-3

TY - JOUR

T1 - The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

AU - Claessens, AKM

AU - Timman, Reinier

AU - van Busschbach, Jan

AU - Bouma, JM

AU - Rademaker-Lakhai, JM

AU - Erdkamp, FLG

AU - Tjan-Heijnen, VC

AU - Bos, Monique

PY - 2020

Y1 - 2020

U2 - 10.1007/s10549-019-05495-3

DO - 10.1007/s10549-019-05495-3

M3 - Article

SN - 0167-6806

VL - 179

SP - 677

EP - 685

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

ER -